Atosiban versus placebo in the treatment of late threatened preterm labor (APOSTEL VIII)

  • Oudijk, M. A. (Chief Investigator (CI))
  • Mol, Ben (Chief Investigator (CI))
  • Van der Post, Joris A.M. (Chief Investigator (CI))
  • Kok, Marjolein (Chief Investigator (CI))

Project: Research

Project Details

Project Description

This study investigated the effectiveness of treatment with Atosiban in women with an increased risk of late preterm labour. On 1 June 2017 a grant from ZonMW, the main funding body in the Netherlands, was awarded to this project (project number 848041004). The study targeted 1,514 patients over a period of 52 months in various hospitals across the Netherlands. A total amount of € 1,416,000 ($ 2,236,904) was allocated to Academisch Medisch Centrum (Academic Medical Centre) Amsterdam
AcronymAPOSTEL VIII
StatusFinished
Effective start/end date1/07/17 → 31/10/21